Nanoscale metal–organic frameworks carrying an immunotherapy payload and administered into tumours alongside a low dose of radiotherapy enhance local and systemic antitumour immunity in mouse models of breast cancer and colorectal cancer.
References
Stewart, B. W. & Wild, C. P. (eds) World Cancer Report 2014 1–2 (World Health Organization, Lyon, France, 2014).
Atun, R. et al. Lancet Oncol. 16, 1153–1186 (2015).
Mole, R. H. Br. J. Radiol. 26, 234–241 (1953).
Andrews, J. R. The Radiobiology of Human Cancer Radiotherapy (University Park Press, Baltimore, MD, USA, 1978).
Ngwa, W. et al. Nat. Rev. Cancer 18, 313–322 (2018).
Tang, C. et al. Cancer Immunol. Res. 2, 831–838 (2014).
Formenti, S. C. & Demaria, S. J. Natl Cancer Inst. 105, 256–265 (2013).
Lu, K. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-018-0203-4 (2018).
Mellor, A. L. & Munn, D. H. Nat. Rev. Immunol. 4, 762–774 (2004).
Toy, R. & Roy, K. Bioeng. Transl. Med. 1, 47–62 (2016).
Ngwa, W. et al. Nanomedicine 9, 1063–1082 (2014).
Chaffer, C. L. & Weinberg, R. A. Science 331, 1559–1564 (2011).
Bernstein, M. B., Krishnan, S., Hodge, J. W. & Chang, J. Y. Nat. Rev. Clin. Oncol. 13, 516–524 (2016).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ngwa, W. Systemic immune effects boost radiotherapy. Nat Biomed Eng 2, 562–563 (2018). https://doi.org/10.1038/s41551-018-0264-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-018-0264-4
- Springer Nature Limited